Invit­ed Speakers

profile

Frank Win­kler

Uni­ver­sität­sklinik Hei­del­berg, DEUTSCHLAND

More info

PORT for Health Oncol­o­gy 2026 Conference 

will fea­ture Frank Win­kler as its Keynote Speak­er, deliv­er­ing insights at the fore­front of con­tem­po­rary oncol­o­gy research.

Frank Win­kler

Uni­ver­sität­sklinik Hei­del­berg, DEUTSCHLAND

More info

Can­cer Biology

Aurelie Poli | AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection

Aurélie Poli

Lux­em­bourg Insti­tute of Health, LUXEMBOURG

More info

Joanna Poźniak | Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

Joan­na Poźniak

KU Leu­ven, BELGIUM

More info

Camille Chatelain | Inducing Immunogenic Tertiary Lymphoid Structures Across Cancer Types With Dendritic Cell Reprogramming

Camille Chate­lain

Lund Uni­ver­si­ty, SWEDEN

More info

Tim Halim | The Role of ILC2 in Tissue Homeostasis and Neoplasia

Tim Hal­im

Can­cer Research UK Cam­bridge Insti­tute, THE UNIT­ED KINGDOM

More info

Can­cer Neuroscience

Andrew Shepherd

Andrew Shep­herd

Uni­ver­si­ty of Texas MD Ander­son Can­cer Cen­ter, THE USA

More info

Christina Møller Andreasen | Remodelling of the Bone Microenvironment During Cancer Infiltration: Insights from Multiplex Imaging and Spatial Transcriptomics

Christi­na Møller Andreasen

Uni­ver­si­ty of South­ern Den­mark, DENMARK

More info

Christoph Klose | Enteric Nervous System-Derived VIP Restrains Differentiation of LGR5+ Stem Cells Towards the Secretory Lineage Impeding Type 2 Immune Programs

Christoph Klose

Char­ité – Berlin Uni­ver­si­ty Med­i­cine, GERMANY

More info

Can­cer Therapy

Helena Florindo | Engineering Nanomedicines for Targeted Neuroimmune Modulation

Hele­na Florindo

Uni­ver­si­ty of Lis­bon, PORTUGAL

More info

Gabriel van der Pluijm | Potentiating Immunotherapy of Urological Cancers with Oncolytic Viruses

Gabri van der Pluijm

Lei­den Uni­ver­si­ty Med­ical Cen­ter, THE NETHERLANDS

More info

Sheeba Irshad

Shee­ba Irshad

King’s Col­lege Lon­don, THE UNIT­ED KINGDOM

More info

Stefaan Van Gool | The War Against Glioblastoma Needs More Than Standard of Care

Ste­faan Van Gool

IOZK Immun-Onkol­o­gis­ches Zen­trum Köln, DEUTSCHLAND

More info

Jürgen Kuball | Uncovering the Spatial Regulation of γδ T Cells: Toward Receptor-Guided Immunotherapy

Jür­gen Kuball

Uni­ver­si­ty Med­ical Cen­ter Utrecht, THE NETHERLANDS

More info

profile

Jarosław Dybko

Low­er Sile­sian Oncol­o­gy Cen­ter in Wro­claw, POLAND

More info

Sébastien Wälchli | Expanding CAR Targets to Non Protein Antigens

Sébastien Wälch­li

Oslo Uni­ver­si­ty Hos­pi­tal, NORWAY

More info

Helen Kakkassery

Helen Kakkassery

King’s Col­lege Lon­don, THE UNIT­ED KINGDOM

More info

Tobias Bald | Targeting the Dark Matter of Cancer with AI-Designed Mini Binder

Tobias Bald

Uni­ver­si­ty of Bonn, DEUTSCHLAND

More info

Com­pa­ny Session

Łukasiewicz – PORT

Mal­wina Woźniak

Łukasiewicz – PORT, POLAND

More info

WPD Pharmaceuticals

Mar­iusz Olejniczak

WPD Phar­ma­ceu­ti­cals, POLAND

More info

Zbig­niew Zasłona

Mol­e­cure, POLAND

More info

Mile­na Mazan

Ryvu Ther­a­peu­tics, POLAND

More info

Marek Kudła

Ardi­gen, POLAND

More info

Mateusz Psurs­ki

Biotech­na, POLAND

More info

Jakub Knurek

Mabion, POLAND

More info

Stay Up to Date

Check the event timetable to ensure you don’t miss any impor­tant or inspir­ing ses­sions. Plan ahead, stay informed, and make the most of every session.

Check Timetable